Healthcare Sales & Marketing Network News: ventricular arrhythmia

Searching News Database: ventricular arrhythmia

HSMN NewsFeed - 7 Jul 2026
AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial
Devices Cardiology

HSMN NewsFeed - 23 Oct 2023
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
Devices Cardiology FDA

HSMN NewsFeed - 18 Sep 2023
Field Medical, Inc. Announces Oversubscribed Seed Round to Advance Next-Generation Cardiac Ablation Technology
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Devices Cardiology Regulatory

HSMN NewsFeed - 30 Aug 2022
Medtronic completes acquisition of Affera
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 13 Jan 2022
PANTHERx Rare(R) Selected by Xeris Pharmaceuticals to Distribute Recorlev(R) (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients with Cushing's Syndrome
Biopharmaceuticals Distribution

HSMN NewsFeed - 26 May 2021
Varian Receives FDA "Breakthrough Device Designation" for its Cardiac Radioablation (CRA) System for Treatment of Refractory Ventricular Tachycardia (VT)
Devices Cardiology FDA

HSMN NewsFeed - 2 Jul 2020
inHEART Raises $4.2 Million to Improve Treatments for Cardiac Arrhythmias With Medical Imaging, Artificial Intelligence and Numerical Simulations
Devices Cardiology Venture Capital

HSMN NewsFeed - 30 Jun 2020
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
Biopharmaceuticals Cardiology Generics Product Launch

HSMN NewsFeed - 18 Feb 2020
Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity
Devices Cardiology Regulatory Product Launch

HSMN NewsFeed - 28 Jan 2020
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 18 Dec 2019
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
Biopharmaceuticals Cardiology Product Launch

HSMN NewsFeed - 25 Jul 2019
U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 24 Jun 2019
Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 20 Jul 2018
FDA Grants Approval of TIBSOVO(R), the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 6 Jun 2018
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine(R) (sargramostim) for the Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Feb 2018
ZYTIGA(R) (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 Feb 2018
Partner Therapeutics (PTx) Acquires Leukine(R) from Sanofi
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 17 Mar 2017
NICE Recommends Boston Scientific CRT-D Devices Powered By EnduraLife(TM) Battery Technology For Treatment Of Heart Failure
Devices Cardiology

HSMN NewsFeed - 8 Feb 2017
FDA Approves Amgen's Parsabiv(TM) (Etelcalcetide), First New Treatment In More Than A Decade For Secondary Hyperparathyroidism In Adult Patients On Hemodialysis
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 11 Jan 2017
Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv(TM) (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis
Biopharmaceuticals

HSMN NewsFeed - 10 Oct 2016
First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT(R) (sunitinib) Extended Disease Free Survival After Surgical Removal
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 4 Apr 2016
First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON(R) (sulfur hexafluoride lipid-type A microspheres) for Injectable Suspension, for Intravenous Use
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 15 Mar 2016
Heart Metabolics Announces Multiple Senior Appointments To Management Team
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 25 Jul 2014
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR(R) (sorafenib) in Patients with Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Jun 2014
Boston Scientific Welcomes New Guidance on the use of Cardiac Technologies for Patients With Arrhythmia or Heart Failure
Devices Cardiology

HSMN NewsFeed - 11 Mar 2014
Bayer and Onyx Report Phase 3 Study Results of NEXAVAR(R) (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Feb 2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 17 Dec 2013
Boston Scientific Announces CE Mark Approval And First Implants Of Its Next-Generation X4 Quadripolar CRT-D Systems
Devices Cardiology Regulatory

HSMN NewsFeed - 15 May 2013
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jan 2013
Phase 3 DECISION Trial of Nexavar(R) (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Dec 2012
FDA Grants Accelerated Approval for SIRTURO(TM) (bedaquiline) as Part of Combination Therapy to Treat Adults with Pulmonary Multi-Drug Resistant Tuberculosis
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Nov 2012
ZYTIGA(R) Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Jul 2012
Addition of Tarceva(R) (erlotinib) to Nexavar(R) (sorafenib) did not Provide Additional Benefit to Patients with Unresectable Liver Cancer Versus Nexavar alone in Phase 3 Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 May 2012
Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 May 2012
FDA Approves BIOTRONIK Next Generation ICDs and CRT-Ds
Devices Cardiology FDA

HSMN NewsFeed - 8 May 2012
St. Jude Medical Announces FDA Approval of Assura(TM) Implantable Defibrillators with Features that Reduce Inappropriate Shocks
Devices Cardiology FDA

HSMN NewsFeed - 16 Apr 2012
St. Jude Medical Announces CE Mark Approval of Smaller ICD with Physician-Inspired Shape
Devices Cardiology Regulatory

HSMN NewsFeed - 10 Apr 2012
Medtronic Receives FDA Approval to Treat Mildly Symptomatic Heart Failure Patients Through Expanded Indication for CRT-D
Devices Cardiology FDA

HSMN NewsFeed - 19 Mar 2012
Cameron Health’s S-ICD(R) System Scheduled for FDA Panel Review on April 26, 2012
Devices Cardiology FDA

HSMN NewsFeed - 30 Jan 2012
Medtronic Announces FDA Approval of DF4 High-Voltage Connector System for Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Devices
Devices Cardiology FDA

HSMN NewsFeed - 21 Jun 2011
St. Jude Medical Announces Japanese Launch of Smaller, Higher Power ICD and CRT-D Devices
Devices Cardiology Regulatory

HSMN NewsFeed - 14 Apr 2011
St. Jude Medical Announces Approval of ShockGuard(TM) Technology with New DecisionTx(TM) Programming for Unify and Fortify Implantable Defibrillators
Devices Cardiology FDA

HSMN NewsFeed - 31 Mar 2011
VICTRELIS(TM) (boceprevir), Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control
Biopharmaceuticals

HSMN NewsFeed - 28 Mar 2011
Medtronic Announces FDA Approval of Protecta(TM) Implantable Defibrillators That Reduce Inappropriate Shocks
Devices Cardiology FDA

HSMN NewsFeed - 25 Jun 2010
Investigational BRINAVESS (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 17 Jun 2010
Medtronic Announces European Launch of Protecta Portfolio with SmartShock Technology Shown to Significantly Reduce Inappropriate Shocks
Devices Cardiology

HSMN NewsFeed - 15 May 2010
New Medtronic Data Shows Health Care Utilization Differs by Type of Implantable Defibrillator Therapy
Devices Cardiology

HSMN NewsFeed - 12 May 2010
St. Jude Medical Announces FDA Approval of Unify CRT-D and Fortify ICD
Devices Cardiology FDA

HSMN NewsFeed - 23 Feb 2010
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 5 Feb 2010
Sorin Group Announces Market Release and First Implant of Next-Generation Cardiac Resynchronization Therapy Defibrillator
Devices Cardiology

HSMN NewsFeed - 4 Feb 2010
St. Jude Medical Announces European Approval of Smaller, Higher Power ICD and CRT-D Devices with New Heart Failure Monitors
Devices Cardiology

HSMN NewsFeed - 16 Oct 2009
FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Oct 2009
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Sep 2009
Salix Receives FDA Marketing Approval for METOZOLV ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 24 Jun 2009
Sorin Group Announces European Market Release and First Implant of Its New-Generation Dual Chamber Implantable Cardioverter Defibrillator
Devices Cardiology

HSMN NewsFeed - 13 May 2009
Medtronic Launches Clinical Trial to Improve Quality of Care for Implantable Defibrillator Patients
Devices Cardiology

HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Feb 2009
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
Regenerative Medicine Cardiology

HSMN NewsFeed - 6 Feb 2009
Medtronic Completes Acquisition of Ablation Frontiers
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 27 Jan 2009
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
Biopharmaceuticals

HSMN NewsFeed - 3 Dec 2008
Medtronic Announces FDA Approval and Market Availability of Sprint Quattro Secure(R) S Single Coil Defibrillation Lead
Devices Cardiology FDA

HSMN NewsFeed - 27 Nov 2008
SORIN GROUP ANNOUNCES EUROPEAN MARKET RELEASE AND FIRST IMPLANT OF NEW-GENERATION CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR
Devices Cardiology

HSMN NewsFeed - 6 Nov 2008
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 12 Sep 2008
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 25 Jul 2008
Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP
Biopharmaceuticals Cardiology

HSMN NewsFeed - 8 Jul 2008
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Biopharmaceuticals

HSMN NewsFeed - 23 Jun 2008
Cambridge Heart Licenses Technology from Massachusetts Institute of Technology
Devices Cardiology Licensing

HSMN NewsFeed - 19 May 2008
Microvolt T-Wave Alternans Found to Be Highly Accurate Predictor of Arrhythmic Events in Meta-Analysis of 6,000 Patients
Devices Cardiology

HSMN NewsFeed - 15 May 2008
Sorin Group Announces FDA Approval of the World's Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator: OVATIO(TM) CRT
Devices Cardiology FDA

HSMN NewsFeed - 14 May 2008
Major Sudden Cardiac Arrest Risk Stratification Trials Unveiled
Devices Cardiology

HSMN NewsFeed - 13 May 2008
CMS Reaffirms National Coverage Determination For Microvolt T-Wave Alternans
Devices Cardiology Reimbursement

HSMN NewsFeed - 13 May 2008
Medtronic Announces FDA Approval of New Vision 3D Wireless Implantable Cardiac Devices
Devices Cardiology FDA

HSMN NewsFeed - 24 Apr 2008
European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 5 Feb 2008
St. Jude Medical Announces European CE Mark Approval of Integrated Irrigation Pump and Cardiac Ablation Generator
Devices Cardiology Regulatory

HSMN NewsFeed - 4 Feb 2008
Premera Blue Cross Covers Microvolt T-Wave Alternans Testing
Diagnostics Cardiology Reimbursement

HSMN NewsFeed - 24 Jan 2008
Cambridge Heart Announces Changes in the Sales and Marketing Organization
Devices Cardiology Personnel

HSMN NewsFeed - 14 Jan 2008
Roche responds to announcement of 'IDEAL' hepatitis C trial results
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 7 Dec 2007
FDA Reviewing Potential Anti-Arrhythmic Claims for Ranexa(R)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Nov 2007
In-Clinic Treatment Protocol Improves Care for Patients at Risk of Sudden Cardiac Arrest
Devices Cardiology

HSMN NewsFeed - 6 Nov 2007
Network Formed to Tackle Cardiac Safety Challenge
Devices Cardiology

HSMN NewsFeed - 2 Nov 2007
Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
Biopharmaceuticals

HSMN NewsFeed - 2 Nov 2007
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Biopharmacetuicals

HSMN NewsFeed - 30 Oct 2007
Significant New Data on Roche's PEGASYS(R) and Hepatitis C Pipeline Compounds to be Featured at 58th Annual AASLD Meeting
Biopharmaceuticals

HSMN NewsFeed - 29 Oct 2007
Cambridge Heart Welcomes John F. McGuire and Keith M. Serzen to the Board of Directors
Devices Cardiology Personnel

HSMN NewsFeed - 22 Oct 2007
Sorin Group Announces the First U.S. Clinical Implant of the World's Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator - OVATIO(TM) CRT
Devices Cardiology

HSMN NewsFeed - 16 Oct 2007
FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 5 Sep 2007
The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Sep 2007
Medtronic to Present Key Clinical Evidence at European Society of Cardiology Congress
Devices Cardiology Monitoring

HSMN NewsFeed - 31 Aug 2007
Sorin Group Launches World's Smallest Implantable Cardioverter Defibrillators in Japan
Devices Cardiology Regulatory

HSMN NewsFeed - 26 Jun 2007
New Patient Monitoring System Allows Routine Checkups of Deadly Heart Conditions Using the Internet
Devices Cardiology Monitoring

HSMN NewsFeed - 24 May 2007
Cambridge Heart Promotes Vincenzo LiCausi to Vice President of Finance and Administration and Chief Financial Officer
Devices Cardiology Personnel

HSMN NewsFeed - 9 May 2007
Boston Scientific Releases Remote Monitoring Data from First 10,000 Patients Using Its Wireless LATITUDE(R) Patient Management System
Devices Cardiology Monitoring

HSMN NewsFeed - 24 Apr 2007
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Mar 2007
Largest Prospective Study of Microvolt T-Wave Alternans in Patients with Non-ischemic Cardiomyopathy Confirms the Predictive Value of MTWA
Devices Cardiology

HSMN NewsFeed - 21 Mar 2007
Cambridge Heart Announces Co-Marketing Agreement with St. Jude Medical and a $12.5 Million Equity Investment
Devices Cardiology

HSMN NewsFeed - 15 Mar 2007
Data Highlighting Cambridge Heart's Non-Invasive HearTwave(R) II System to be Presented in Late Breaker at American College of Cardiology Meeting
Devices Cardiology

HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Jan 2007
iCardiac Technologies Enters Into Cardiac Safety Alliance With Pfizer
Biopharmaceuticals Cardiology

HSMN NewsFeed - 18 Dec 2006
Cambridge Heart Announces Management Changes
Diagnostics Devices Cardiology Personnel

HSMN NewsFeed - 12 Dec 2006
Valeant Pharmaceuticals Initiates Infergen(R) Phase 4 Study
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2006
Largest Prospective Study of Microvolt T-Wave Alternans Demonstrates This Technology's Predictive Value for Sudden Cardiac Death in Patients With Preserved Left Ventricular Function After Acute Myocardial Infarction
Devices Cardiology

HSMN NewsFeed - 15 Nov 2006
Results of Clinical Trial Demonstrate That a New, Non-invasive Test is Comparable to Invasive Tests in Identifying Patients Who Could Benefit from ICDs
Devices Cardiology

HSMN NewsFeed - 14 Nov 2006
Sorin Group Initiates Multi-Center 'OPTION' Study in Europe
Devices Cardiology

HSMN NewsFeed - 13 Nov 2006
WellPoint To Cover Microvolt T-Wave Alternans Testing
Devices Cardiology Reimbursement

HSMN NewsFeed - 7 Nov 2006
HCSC to Cover Microvolt T-Wave Alternans Testing
Devices Cardiology Diagnostics Reimbursement

HSMN NewsFeed - 6 Nov 2006
Results from St. Jude Medical's Study of Microvolt T-Wave Alternans to be Presented at the 2006 American Heart Association Scientific Sessions
Devices Cardiology

HSMN NewsFeed - 30 Oct 2006
Valeant Pharmaceuticals Presents End-of-Treatment Results of DIRECT Trial for Infergen at the American Association for the Study of Liver Diseases 2006 Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 10 Sep 2006
Three of Medtronic's Heart Failure Clinical Studies to Be Highlighted at Heart Failure Society of America Annual Scientific Meeting
Devices Cardiology

HSMN NewsFeed - 29 Jun 2006
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Jun 2006
Microvolt T-Wave Alternans Testing To Be Covered by CIGNA HealthCare
Devices Cardiology Reimbursement

HSMN NewsFeed - 16 May 2006
Sorin Group Announces FDA Approval of World's Smallest Implantable Cardioverter Defibrillator; OVATIO(TM) Offers Advanced Pacing and Defibrillation Technology to Patients at Risk for Sudden Cardiac Arrest
Devices Cardiology FDA

HSMN NewsFeed - 8 May 2006
Largest US Study Confirms Predictive Ability of Microvolt T-Wave Alternans
Devices Cardiology

Return to NewsFeed

Additional items found! 45

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 45 additional stories matching:
ventricular arrhythmia
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!